Dietary Manganese Promotes Staphylococcal Infection of the Heart

Lillian J Juttukonda1, Evelien T M Berends2, Joseph P Zackular1

  • 1Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, 1161 21(st) Avenue South, MCN A-5102, Nashville, TN 37232, USA.

Cell Host & Microbe
|September 26, 2017
PubMed

Insights

Dietary manganese (Mn) supplementation enhances Staphylococcus aureus virulence and fatal heart infections in mice. High Mn diets overwhelm host defenses, making bacteria more resistant to immune cells and leading to increased mortality.

Area of Science:

  • Microbiology
  • Immunology
  • Nutritional Science

Background:

  • Dietary metals can influence infection risk.
  • Mechanisms by which manganese (Mn) affects infection are not well understood.
  • Staphylococcus aureus causes bacterial endocarditis, a serious systemic infection.

Purpose of the Study:

  • To investigate how dietary manganese levels impact Staphylococcus aureus infection outcomes.
  • To explore the role of manganese bioavailability in bacterial virulence and host defense.

Main Methods:

  • Mice were fed diets with varying manganese levels.
  • Infection models using Staphylococcus aureus were established, focusing on systemic and heart infections.
  • Manganese levels and localization in infected tissues were analyzed.
  • Bacterial virulence factors and host immune responses were assessed.

Main Results:

  • High dietary manganese increased Staphylococcus aureus virulence and mortality from endocarditis in mice.
  • Elevated manganese levels were observed in infected tissues of mice on high Mn diets.
  • The host's manganese-sequestering protein, calprotectin, did not limit manganese availability within heart abscesses.
  • Excess bioavailable manganese in the heart enhanced Staphylococcus aureus's ability to neutralize reactive oxygen species and resist neutrophil killing.

Conclusions:

  • Dietary manganese levels significantly dictate the outcome of Staphylococcus aureus infections.
  • Excess manganese bioavailability in the heart promotes bacterial survival and virulence.
  • Dietary modifications can overwhelm host antimicrobial strategies, leading to severe infections.

Related Concept Videos

Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
605
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
342
Essential Minerals for Bone Health01:31

Essential Minerals for Bone Health

The minerals contained in all of the food we consume are essential for our organ systems. However, certain essential minerals, such as calcium, phosphorus, magnesium, manganese, and fluoride, largely affect bone health.
Calcium and Phosphorus
Calcium is a critical component of bones, especially in the form of calcium phosphate and calcium carbonate. Since the body cannot make calcium, it must be obtained from the diet. However, calcium cannot be absorbed from the small intestine without...
6.7K
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
871
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
401
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
471